Headlines

TII Gastric Bypass Benefits Outweigh Risks after Two Years?

A new international study found that two years post-surgery, those who had gastric bypass have better diabetes control, but they also had higher risks of infection and fractures.

Metformin use associated with reduced risk of developing open-angle glaucoma

Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published online by JAMA Ophthalmology.

Wired – Glucose-Sensing Contacts and More Brilliant Diabetes Tech

200 million people on this planet worry about the same invisible villain: their blood glucose. High, low, just right? For many of these diabetics, it’s a medical version of Goldilocks that entails four or more blood-test finger pricks a day and a jab in the thigh with a needle full of insulin at mealtimes.

Joslin Diabetes – Ordering Your Exercise to Avoid Hypoglycemia?

People with type 1 diabetes have to be cautious when they exercise or do any kind of physical activity to avoid setting their blood glucose levels out of sorts.

Research Shows That Intermittent Fasting Could Lead to Abdominal Weight Gain

Intermittent fasting – the practice of alternating periods of fasting with periods of “feasting” – has gained popularity in recent years among dieters.

DiabetesMine – Abbott’s New Precision Neo Meter Lacks Features, Aims to ‘Skip the Copay’

If a glucose meter could make cappuccino, I’d be all over that. That’s what I expected with Abbott Diabetes Care’s newest meter, the FreeStyle Precision Neo, launched here in the States earlier this Spring. But sadly, the meter doesn’t deliver on the promise of delivering my metaphoric cappuccino. It hardly even brews drip coffee, if […]

Which New Blood Glucose Meter Should You Buy in 2015

The number of blood glucose meters on the market today is staggering, and one of the most frequently asked questions in diabetes forums is “What meter do you use?” So, how do you choose?

FDA Approves Innovative Breath Test to Diagnose Gastroparesis

The FDA recently announced the approval of the Gastric Emptying Breath Test (GEBT) as a diagnostic tool for gastroparesis – this condition is, though not as well known, a common complication of diabetes.

CNN – ‘Natural’ and other food labels that sound legitimate but may not be

For example, food and beverage companies can label their products “natural” without having to meet a clear definition by the FDA. In the absence of regulations, policy groups and consumer research often step in to tell us more about the safety and consistency of the latest wonder food (or label).

FDA Issues Warning for Type 2 Diabetes Drugs Including Canagliflozin, Dapagliflozin and Empagliflozin

A certain class of type 2 diabetes drugs can lead to a life-threatening condition called ketoacidosis, the U.S. Food and Drug Administration warns.

Can A Little Extra Weight Be Protective in Type 2 Diabetes?

Research published by the American College of Physicians found that individuals with type 2 diabetes who were overweight, but not obese, had better survival rates from cardiovascular problems than people who were underweight or normal-weight.

Novel Exercise Approaches to Managing Activity-Induced Hypoglycemia

Given that fear of hypoglycemia during exercise is a known barrier to exercise participation, particularly for insulin users with diabetes, it is worthwhile to discuss some novel approaches to using exercise itself to manage blood glucose levels during activities.

Mice Research Shows that Fish Oil May Help with Diabetic Neuropathy

Researchers used a mouse model of diabetes to study the effect of fish oil. Diabetic mice were fed a high-fat diet and treated with daily injections of resolvin or given a high-fat diet in which half the fat came from fish oil. The results were compared to healthy, non-diabetic mice.

NPR – For Headaches, A Lifestyle Change May Be Better Than A Doctor Visit

People who go to the doctor for headaches are increasingly likely to be sent for advanced testing and treatment, a study finds. That testing is expensive, it may not be necessary and it could even be harmful, says lead researcher Dr. John Mafi, of Beth Israel Deaconess Medical Center in Boston.

A Complicated Case of the Heart – FDA Meets on Heart Safety of Diabetes Drugs

The FDA just held a public meeting to discuss the results from two major heart safety trials conducted on the DPP-4 inhibitor drugs Onglyza and Nesina. Both trials suggested that the drugs do not increase the risk of cardiovascular events, such as heart attacks and strokes. Following a long day of testimonies, the FDA committee […]

CNN – Trick your brain to avoid ‘portion distortion’

t’s impossible to live your healthiest life without keeping your portion sizes in check. It just comes with the territory, like putting effort into your sweat sessions and making smart choices when browsing the supermarket aisles. “When people overeat, it leads to irregularity in blood sugar.

Diabetes Mine – Around the Diabetes Blogosphere: April 2015 Edition

It’s amazing that another month has gone by already. It’s certainly been a busy one here at the ‘Mine, and there’s been a lot going on around the Diabetes Online Community (DOC) as well.

Insulin Nation – Death By Expired Insulin Prescription

It’s been 16 months since Dan and Judy Houdeshell lost their son, Kevin, and they are trying to accept that they may never know exactly what happened. Kevin, who was on insulin therapy, was found dead in his home in Sheffield Lake, Ohio on January 8th, 2014. He had been without insulin for nine days […]

New Roche Meter & App to Bring Mobile Insulin Recommendations, Despite Recall

In the coming months, we’ll see the Roche Accu-Chek Connect system hit the market here in the States — giving us the first mobile app approved by the FDA that actually offers insulin dosing recommendations, via a built-in bolus calculator.

UCLA: Metformin is inexpensive and effective, but underused by diabetics

Few doctors are prescribing a low-cost drug that has been proven effective in preventing the onset of diabetes, according to a UCLA study. The study, published in the peer-reviewed journal Annals of Internal Medicine, found that only 3.7 percent of U.S. adults with pre-diabetes were prescribed metformin during a recent three-year period.



Other News

ACLS Class

  • Get ACLS and PALS certified online with ACLSclass.com’s fast programs.
  • Health Partner